Skip to main content
ROCKET PHARMACEUTICALS, INC. logo

ROCKET PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · RCKT ISIN · US77313F1066 LEI · 549300R7VV82YUIN4Y93 US Manufacturing
Filings indexed 889 across all filing types
Latest filing 2025-08-18 Director's Dealing
Country US United States of America
Listing US RCKT

About ROCKET PHARMACEUTICALS, INC.

https://www.rocketpharma.com/

Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company that develops gene therapies for rare and devastating diseases. The company's mission is to provide cures by correcting the root cause of disease at the genetic level. It utilizes a multi-platform approach, employing both ex vivo lentiviral (LV) and in vivo adeno-associated viral (AAV) technologies. This strategy allows for the selection of the most suitable platform for specific conditions, with a focus on diseases with high unmet needs, including bone marrow-derived and cardiovascular disorders. Rocket aims to advance a sustainable pipeline of first-in-class investigational genetic therapies for patients.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2025-08-18 English
Regulatory Filings 2025
Regulatory Filings
2025-08-18 English
Regulatory Filings 2025
Regulatory Filings
2025-08-18 English
Regulatory Filings 2025
Regulatory Filings
2025-08-18 English
Regulatory Filings 2025
Regulatory Filings
2025-08-14 English
Regulatory Filings 2025
Regulatory Filings
2025-08-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.